Search

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies. 

Abt Global and its partner, MDRC, evaluated a Job Corps pilot program, the Cascades Job Corps College and Career Academy (CCCA), for the U.S. Department of Labor (DOL). The Cascades pilot was an ambitious and evidence-based attempt to increase education…

The Workforce Innovation Fund (WIF), funded by the U.S. Department of Labor, was an initiative to develop and test new services and strategies in the public workforce system. WIF required that the 43 grantees each demonstrate how their proposed…

Abt’s Evaluation Technical Assistance team has helped hundreds of evaluators provide real-world, rigorous evidence of program effectiveness.

.

Under traditional Medicare, the Centers for Medicare and Medicaid Services (CMS) pays providers separately for each service delivered, which may incentivize medically unnecessary care.  Providers who participate in CMS’s Bundled Payment for Care…

Our work has helped address the supply of and demand for illegal drugs and the misuse of legal substances for federal, state and local agencies, as well as other key stakeholders.

For a decade, Abt Global has worked to understand the impact and prevent the spread of the disease in the United States and abroad, including in low- and middle-income countries.

For more than 30 years, Abt Global has conducted research on workforce development programs and their effectiveness raising participants’ skills to meet employers’ workforce needs and to increase employment and earnings prospects for workers.